Anthropic Plans to Enter Drug Development

Anthropic, the AI company behind the Claude chatbot, is reportedly planning to develop its own drugs. The move signals a significant expansion beyond AI into biotechnology, leveraging its machine learning capabilities for drug discovery. This matters because it underscores the growing trend of AI companies diversifying into high-stakes sectors like pharmaceuticals.

Sources (1)